Cargando…
Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase
Hepatocellular carcinoma (HCC) is a frequently diagnosed malignancy with a high mortality rate. Cisplatin (CDDP) is a widely applied anti-cancer drug. However, a large population of liver cancer patients developed CDDP resistance. The polypyrimidine tract binding protein (PTBP1) is an RNA-binding pr...
Autores principales: | Tian, Ruimin, Li, Yanfei, Shen, Xiaojie, Li, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505300/ https://www.ncbi.nlm.nih.gov/pubmed/37724122 http://dx.doi.org/10.1515/med-2023-0756 |
Ejemplares similares
-
The Role of Glutamine and Glutaminase in Pulmonary Hypertension
por: Wang, Shang, et al.
Publicado: (2022) -
Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition
por: Muir, Alexander, et al.
Publicado: (2017) -
PTBP1 mRNA isoforms and regulation of their translation
por: Arake de Tacca, Luisa M., et al.
Publicado: (2019) -
Metabolic Heterogeneity, Plasticity, and Adaptation to “Glutamine Addiction” in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase—ω-Amidase (Glutaminase II)] Pathway
por: Cooper, Arthur J. L., et al.
Publicado: (2023) -
PTBP1-mediated regulation of AXL mRNA stability plays a role in lung tumorigenesis
por: Cho, Chun-Yu, et al.
Publicado: (2019)